Ain-Shams Journal of Anesthesiology

Table 3 Comparison between study groups as regards organisms revealed from cultures before treatment

From: A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)

	Group A	Group B	A/B
Klebsiella	11 (35.0%)	6 (20.0%)	0.288
Acinetobacter	3 (10.0%)	11(35.0%)	0.058
Pseudomonas	19 (60.0%)	11(35.0%)	0.113
Citrobacter	0 (0.0%)	1 (5.0%)	0.311
Staphylocci	0 (0.0%)	2 (10.0%)	0.147
Provedinetia	1 (5.0%)	1 (5.0%)	1.000
Proteus	1 (5.0%)	1 (5.0%)	1.000
Enterobacter	1 (5.0%)	0 (0.0%)	0.311

Data are presented as number of cases and percentage of each to total number of cases in each group. p value > 0.05 NS
x² chi-square test

Back to article page